PortfoliosLab logo
MetLife, Inc. (MET)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US59156R1086

CUSIP

59156R108

IPO Date

Apr 5, 2000

Highlights

Market Cap

$51.68B

EPS (TTM)

$5.94

PE Ratio

12.77

PEG Ratio

1.01

Total Revenue (TTM)

$54.64B

Gross Profit (TTM)

$54.64B

EBITDA (TTM)

$3.45B

Year Range

$65.21 - $88.48

Target Price

$90.43

Short %

1.27%

Short Ratio

1.95

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in MetLife, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


200.00%300.00%400.00%500.00%600.00%700.00%NovemberDecember2025FebruaryMarchApril
606.06%
271.48%
MET (MetLife, Inc.)
Benchmark (^GSPC)

Returns By Period

MetLife, Inc. had a return of -7.58% year-to-date (YTD) and 7.67% in the last 12 months. Over the past 10 years, MetLife, Inc. had an annualized return of 7.99%, while the S&P 500 had an annualized return of 10.11%, indicating that MetLife, Inc. did not perform as well as the benchmark.


MET

YTD

-7.58%

1M

-10.41%

6M

-7.51%

1Y

7.67%

5Y*

21.83%

10Y*

7.99%

^GSPC (Benchmark)

YTD

-6.06%

1M

-3.27%

6M

-4.87%

1Y

9.44%

5Y*

14.30%

10Y*

10.11%

*Annualized

Monthly Returns

The table below presents the monthly returns of MET, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20255.65%0.26%-6.83%-6.35%-7.58%
20244.82%1.41%6.27%-4.09%2.61%-3.01%9.49%1.63%6.45%-4.92%13.30%-7.20%27.68%
20230.90%-1.06%-19.22%5.85%-18.43%14.09%11.39%1.42%-0.68%-4.61%6.96%3.93%-5.49%
20227.31%1.44%4.04%-6.55%3.37%-6.83%0.73%2.52%-5.52%20.45%5.48%-5.65%19.23%
20212.56%20.75%5.54%4.67%3.46%-8.43%-3.59%8.31%-0.44%1.73%-5.89%6.53%37.43%
2020-2.47%-13.29%-28.44%18.02%1.22%1.42%3.64%2.86%-3.35%1.83%23.48%1.69%-3.42%
201911.23%-0.13%-5.80%8.36%1.10%7.49%-0.50%-9.52%6.46%-0.78%7.67%2.12%28.84%
2018-4.92%-3.11%-0.65%3.88%-2.61%-5.20%4.91%1.25%1.81%-11.84%9.41%-8.00%-15.77%
20170.96%-3.62%0.72%-1.91%-2.35%8.60%0.11%-4.47%10.93%3.14%0.91%-5.81%6.03%
2016-7.38%-11.40%11.07%2.64%1.00%-12.56%7.31%1.54%2.37%5.69%17.14%-2.04%11.78%
2015-14.03%9.31%-0.55%1.46%1.89%7.14%-0.45%-10.12%-5.89%6.85%1.41%-5.64%-10.87%
2014-9.03%3.30%4.20%-0.85%-2.71%9.09%-5.33%4.07%-1.86%0.97%2.53%-2.73%0.32%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MET is 60, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of MET is 6060
Overall Rank
The Sharpe Ratio Rank of MET is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of MET is 5353
Sortino Ratio Rank
The Omega Ratio Rank of MET is 5454
Omega Ratio Rank
The Calmar Ratio Rank of MET is 6868
Calmar Ratio Rank
The Martin Ratio Rank of MET is 6666
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for MetLife, Inc. (MET) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


The chart of Sharpe ratio for MET, currently valued at 0.25, compared to the broader market-2.00-1.000.001.002.003.00
MET: 0.25
^GSPC: 0.46
The chart of Sortino ratio for MET, currently valued at 0.51, compared to the broader market-6.00-4.00-2.000.002.004.00
MET: 0.51
^GSPC: 0.77
The chart of Omega ratio for MET, currently valued at 1.08, compared to the broader market0.501.001.502.00
MET: 1.08
^GSPC: 1.11
The chart of Calmar ratio for MET, currently valued at 0.33, compared to the broader market0.001.002.003.004.005.00
MET: 0.33
^GSPC: 0.47
The chart of Martin ratio for MET, currently valued at 1.12, compared to the broader market-5.000.005.0010.0015.0020.00
MET: 1.12
^GSPC: 1.94

The current MetLife, Inc. Sharpe ratio is 0.25. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of MetLife, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.25
0.46
MET (MetLife, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History

MetLife, Inc. provided a 2.90% dividend yield over the last twelve months, with an annual payout of $2.18 per share. The company has been increasing its dividends for 24 consecutive years.


0.00%1.00%2.00%3.00%4.00%$0.00$0.50$1.00$1.50$2.0020142015201620172018201920202021202220232024
Dividends
Dividend Yield
PeriodTTM20242023202220212020201920182017201620152014
Dividend$2.18$2.16$2.06$1.98$1.90$1.82$1.74$1.66$0.40$0.00$0.00$0.00

Dividend yield

2.90%2.63%3.12%2.74%3.04%3.88%3.41%4.04%0.79%0.00%0.00%0.00%

Monthly Dividends

The table displays the monthly dividend distributions for MetLife, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2025$0.00$0.55$0.00$0.00$0.55
2024$0.00$0.52$0.00$0.00$0.55$0.00$0.00$0.55$0.00$0.00$0.55$0.00$2.16
2023$0.00$0.50$0.00$0.00$0.52$0.00$0.00$0.52$0.00$0.00$0.52$0.00$2.06
2022$0.00$0.48$0.00$0.00$0.50$0.00$0.00$0.50$0.00$0.00$0.50$0.00$1.98
2021$0.00$0.46$0.00$0.00$0.48$0.00$0.00$0.48$0.00$0.00$0.48$0.00$1.90
2020$0.00$0.44$0.00$0.00$0.46$0.00$0.00$0.46$0.00$0.00$0.46$0.00$1.82
2019$0.00$0.42$0.00$0.00$0.44$0.00$0.00$0.44$0.00$0.00$0.44$0.00$1.74
2018$0.00$0.40$0.00$0.00$0.42$0.00$0.00$0.42$0.00$0.00$0.42$0.00$1.66
2017$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.40$0.00$0.40
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2015$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2014$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00

Dividend Yield & Payout


Dividend Yield
5.0%10.0%15.0%20.0%25.0%
MET: 2.9%
MetLife, Inc. has a dividend yield of 2.90%, which is quite average when compared to the overall market.
Payout Ratio
200.0%400.0%600.0%800.0%1,000.0%1,200.0%
MET: 27.1%
MetLife, Inc. has a payout ratio of 27.09%, which is quite average when compared to the overall market. This suggests that MetLife, Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%NovemberDecember2025FebruaryMarchApril
-14.25%
-10.07%
MET (MetLife, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the MetLife, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the MetLife, Inc. was 82.93%, occurring on Mar 5, 2009. Recovery took 3006 trading sessions.

The current MetLife, Inc. drawdown is 14.25%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-82.93%Oct 8, 2007355Mar 5, 20093006Feb 11, 20213361
-43.15%Dec 11, 2000455Oct 7, 2002376Apr 5, 2004831
-35.09%Nov 28, 2022117May 16, 2023217Mar 27, 2024334
-21.97%Nov 29, 202488Apr 8, 2025
-19.46%Apr 21, 202258Jul 14, 202275Oct 28, 2022133

Volatility

Volatility Chart

The current MetLife, Inc. volatility is 19.02%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%NovemberDecember2025FebruaryMarchApril
19.02%
14.23%
MET (MetLife, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of MetLife, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how MetLife, Inc. is priced in the market compared to other companies in the Insurance - Life industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio
20.040.060.080.0100.0
MET: 12.8
The chart displays the Price-to-Earnings (P/E) ratio for MET, comparing it with other companies in the Insurance - Life industry. Currently, MET has a P/E ratio of 12.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
0.51.01.52.02.53.0
MET: 1.0
The chart shows the Price/Earnings to Growth (PEG) ratio for MET compared to other companies in the Insurance - Life industry. MET currently has a PEG ratio of 1.0. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
2.04.06.08.010.0
MET: 0.7
This chart shows the Price-to-Sales (P/S) ratio for MET relative to other companies in the Insurance - Life industry. Currently, MET has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
2.04.06.08.0
MET: 1.8
The chart illustrates the Price-to-Book (P/B) ratio for MET in comparison with other companies in the Insurance - Life industry. Currently, MET has a P/B value of 1.8. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items